
Learn about vaccine requirements, exemptions, and federal privacy protections in K-12 and daycare settings.

The FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend updating the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain, citing the current vaccine's ineffectiveness against emerging variants. Despite the absence of safety data, the committee emphasized the importance of vaccine effectiveness, while noting the potential for rapid variant evolution which might impact vaccine efficacy. Manufacturers like Moderna, Pfizer, and Novavax presented promising data for their new vaccine candidates, with an emphasis on preparedness to meet the FDA's upcoming strain decision.

Barbara Loe Fisher, shedding light on the implications of WHO's proposed amendments.

View NVIC's Barbara Loe Fisher's testimony on Senator Ron Johnson's rountable discussion on "Federal Health Agencies and the COVID Cartel: What Are They Hiding?"

Read about the myths and facts surrounding the National Childhood Vaccine Injury Compensation Act of 1986 that NVIC's co-founders worked with Congress to pass.
Read about the record-breaking number of good vaccine-related bills that passed during the 2023 state legislative session.
.png)
Learn about the ACIP recommendation for Pfizer's Abrysvo RSV vaccine in pregnant women, the controversy surrounding its testing, and the potential impact on preterm births – all in our eye-opening article on RSV vaccination strategies.

Discover how CDC's V-safe vaccine tracking app could be developed to track all vaccinations.

Learn about federal law and parent consent rights for vaccination in school-based health centers.
Impending Changes to Vaccine Injury Compensation
Stay informed on impending changes to vaccine injury compensation with Theresa Wrangham's latest article. Learn about the expected release of a pivotal report by the National Academy of Medicine and its potential impact on the Vaccine Injury Table, alongside updates on membership vacancies and compensation trends.